59 related articles for article (PubMed ID: 2324586)
1. [The clinical significance of antibody against oncofetal antigen-I in patients with gynecologic tumors].
Higuchi M; Ohsawa S
Nihon Gan Chiryo Gakkai Shi; 1990 Jan; 25(1):25-30. PubMed ID: 2324586
[TBL] [Abstract][Full Text] [Related]
2. [A study on clinical significance of oncofetal antigen-1 in gynecologic tumors].
Takahashi M
Nihon Sanka Fujinka Gakkai Zasshi; 1984 Dec; 36(12):2613-8. PubMed ID: 6520482
[TBL] [Abstract][Full Text] [Related]
3. Oncofetal antigen: a tumor-associated fetal antigen immunogenic in man.
Irie RF; Giuliano AE; Morton DL
J Natl Cancer Inst; 1979 Aug; 63(2):367-73. PubMed ID: 88539
[TBL] [Abstract][Full Text] [Related]
4. The clinical significance of antibody against oncofetal antigen-I (anti-OFA-I) in patients with gynecologic tumors.
Higuchi M; Takahashi M; Takeuchi Y; Hando T; Takeuchi S
Asia Oceania J Obstet Gynaecol; 1986 Sep; 12(3):419-23. PubMed ID: 3778321
[No Abstract] [Full Text] [Related]
5. [The clinical significance of OFA-I in the immunological rejection mechanism in trophoblasts].
Takeuchi Y
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Sep; 37(9):1893-8. PubMed ID: 3902999
[TBL] [Abstract][Full Text] [Related]
6. Isolation and immunochemical characterization of antibodies from the sera of cancer patients which are reactive against human melanoma cell membranes by affinity chromatography.
Gupta RK; Silver HK; Reisfeld RA; Morton DL
Cancer Res; 1979 May; 39(5):1683-95. PubMed ID: 427806
[TBL] [Abstract][Full Text] [Related]
7. Prolonged survival for melanoma patients with elevated IgM antibody to oncofetal antigen.
Jones PC; Sze LL; Liu PY; Morton DL; Irie RF
J Natl Cancer Inst; 1981 Feb; 66(2):249-54. PubMed ID: 6935475
[TBL] [Abstract][Full Text] [Related]
8. Oncofetal antigen-I: distribution in human tumors.
Rees WV; Irie RF; Morton DL
J Natl Cancer Inst; 1981 Sep; 67(3):557-62. PubMed ID: 6268878
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibody identification and characterization of a Mr 43,000 membrane glycoprotein associated with human breast cancer.
Edwards DP; Grzyb KT; Dressler LG; Mansel RE; Zava DT; Sledge GW; McGuire WL
Cancer Res; 1986 Mar; 46(3):1306-17. PubMed ID: 3510721
[TBL] [Abstract][Full Text] [Related]
10. Proliferation index determined by MIB-1 and recurrence in endometrial cancer.
Geisler JP; Wiemann MC; Zhou Z; Miller GA; Geisler HE
Gynecol Oncol; 1996 Jun; 61(3):373-7. PubMed ID: 8641618
[TBL] [Abstract][Full Text] [Related]
11. [Humoral and cellular immune response in patients with gynecologic cancer].
Guerrero B; Campodónico I; Hammer I
Rev Chil Obstet Ginecol; 1978; 43(4):225-9. PubMed ID: 550208
[No Abstract] [Full Text] [Related]
12. Demonstration of antibodies in patients' sera, directed against nonspecific cross-reacting antigen.
von Kleist S; King M; Havemann K
J Natl Cancer Inst; 1978 Dec; 61(6):1385-91. PubMed ID: 281546
[TBL] [Abstract][Full Text] [Related]
13. [Immunology and cancer. A review for gynecologic oncology].
Koenig D
Geburtshilfe Frauenheilkd; 1977 Nov; 37(11):961-73. PubMed ID: 336455
[No Abstract] [Full Text] [Related]
14. Humoral immune response to intralymphatic immunotherapy for disseminated melanoma: correlation with clinical response.
Ahn SS; Irie RF; Weisenburger TH; Jones PC; Juillard G; Roe DJ; Morton DL
Surgery; 1982 Aug; 92(2):362-7. PubMed ID: 7101129
[TBL] [Abstract][Full Text] [Related]
15. Subsets of oncofetal antigen-induced T-cells: ability to mediate antitumor immune response.
Gautam S; Deodhar SD
J Natl Cancer Inst; 1983 May; 70(5):923-30. PubMed ID: 6601736
[TBL] [Abstract][Full Text] [Related]
16. Tumor-reactive human immunoglobulin G monoclonal antibody from a melanoma patient.
Kan-Mitchell J; White WL; Mitchell MS
Cancer Res; 1989 Aug; 49(16):4536-41. PubMed ID: 2472881
[TBL] [Abstract][Full Text] [Related]
17. Human breast carcinoma patients develop clonable oncofetal antigen-specific effector and regulatory T lymphocytes.
Rohrer JW; Barsoum AL; Dyess DL; Tucker JA; Coggin JH
J Immunol; 1999 Jun; 162(11):6880-92. PubMed ID: 10352310
[TBL] [Abstract][Full Text] [Related]
18. The cancer recognition (CARE) antibody test.
Thornthwaite JT; McDuffee EC; Harris RB; Secor McVoy JR; Lane IW
Cancer Lett; 2004 Dec; 216(2):227-41. PubMed ID: 15533599
[TBL] [Abstract][Full Text] [Related]
19. 37 kiloDalton oncofetal antigen protein and immature laminin receptor protein are identical, universal T-cell inducing immunogens on primary rodent and human cancers.
Coggin JH; Barsoum AL; Rohrer JW
Anticancer Res; 1999; 19(6C):5535-42. PubMed ID: 10697612
[TBL] [Abstract][Full Text] [Related]
20. A review of tumor antigens in gynecologic malignancies.
Gall SA
J Reprod Med; 1975 Jan; 14(1):12-6. PubMed ID: 162963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
